United States · Bill · HR
H.R. 7822 (117th)
Baby Formula Emergency Act
Introduced
18 May 2022
Last action
—
Status
Referred to the Subcommittee on Trade.
Sponsors
—
Subjects
Discovery layer
Source updated
3 January 2025
Summary
Baby Formula Emergency Act This bill authorizes the President, during an infant formula shortage or potential shortage, to allow the production and marketing or duty-free importation of infant formula that meets specified criteria, regardless of Food and Drug Administration (FDA) requirements. The criteria include that the United States has not imposed any sanctions with respect to the manufacturer of the formula and the FDA has not determined that such formula is unsafe. Further, the President must notify Congress about determinations related to supply shortages of infant formula.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 18 May 2022
Introduced in House (PDF)
Introduced in House · EN · 18 May 2022
Introduced in House
summary · EN · 18 May 2022
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/117th-congress/house-bill/7822
- Open data entity: https://api.congress.gov/v3/bill/117/hr/7822